Jun Xing

Jun Xing is a Senior Director at Sanofi, focusing on immunology within Global Development Medical Affairs. They have led statistical projects, specifically for heart failure, and have extensive experience with early-phase and registrational studies, including significant roles in the development of Clazakizumub and Belatacept. Previously, Jun held positions at Bristol-Myers Squibb, where they contributed as a Principal Biostatistician and Senior Associate Director. Jun is currently pursuing a Ph.D. in Biostatistics at the University of California, Los Angeles, and holds degrees in Biophysics and Biochemistry from Fudan University and the University of California, Riverside, respectively.